Clinical Trial: DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277114) titled 'DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR' on Nov. 30.

Brief Summary: The goal of this clinical trial is to learn if the short and long term effect of drug coated balloon (DCB) is non-inferior to drug eluting stent (DES) in patients with severe coronary calcification after optimal calcium modification assessed by quantitative flow ratio (QFR). The main questions it aims to answer are:

1. Researchers will compare to see if DCB is non-inferior to DES when evaluated by major cardiovascular adverse events (MACE) one year after percutaneous coronary intervention (PCI).

2. Researchers will c...